Abstract
A polygenic score (PGS) for Alzheimer's disease (AD) was derived recently from data on genome-wide significant loci in European ancestry populations. We applied this PGS to populations in 17 European countries and observed a consistent association with the AD risk, age at onset and cerebrospinal fluid levels of AD biomarkers, independently of apolipoprotein E locus (APOE). This PGS was also associated with the AD risk in many other populations of diverse ancestries. A cross-ancestry polygenic risk score improved the association with the AD risk in most of the multiancestry populations tested when the APOE region was included. Finally, we found that the PGS/polygenic risk score captured AD-specific information because the association weakened as the diagnosis was broadened. In conclusion, a simple PGS captures the AD-specific genetic information that is common to populations of different ancestries, although studies of more diverse populations are still needed to better characterize the genetics of AD.
| Original language | English |
|---|---|
| Pages (from-to) | 1598-1610 |
| Number of pages | 24 |
| Journal | Nature Genetics |
| Volume | 57 |
| Issue number | 7 |
| Early online date | 18 Jun 2025 |
| DOIs | |
| Publication status | Published - 1 Jul 2025 |
Bibliographical note
Publisher Copyright:© 2025. The Author(s).
Keywords
- Alzheimer Disease/genetics
- Humans
- Multifactorial Inheritance/genetics
- Genetic Predisposition to Disease
- White People/genetics
- Genome-Wide Association Study
- Europe/epidemiology
- Apolipoproteins E/genetics
- Female
- Risk Factors
- Male
- Polymorphism, Single Nucleotide
- Aged
- Biomarkers/cerebrospinal fluid
- Genetic Risk Score
Fingerprint
Dive into the research topics of 'Transferability of European-derived Alzheimer's disease polygenic risk scores across multiancestry populations'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver